FLUIBRON

This brand name is authorized in Brazil, Cyprus, Turkey

Active ingredients

The drug FLUIBRON contains one active pharmaceutical ingredient (API):

1 Ambroxol UNII CC995ZMV90 - AMBROXOL HYDROCHLORIDE

Ambroxol induces activation of the surfactant system by acting directly on the type II pneumocytes of the alveoles and the Clara cells in the region of the small airways. It promotes the formation and outward transfer of surface-active material in the alveolar and bronchial region of the foetal and adult lungs. Read about Ambroxol

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
FLUIBRON Syrup	Υπουργείο Υγείας (CY)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
R05CB06	Ambroxol	R Respiratory system → R05 Cough and cold preparations → R05C Expectorants, excl. combinations with cough suppressants → R05CB Mucolytics
Discover more medicines within R05CB06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 508501601136421, 508501602132421, 508501603139428, 508501604135426
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699527573467, 8699527573481